262 related articles for article (PubMed ID: 27567887)
1. Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function.
Oh YS; Choi JH; Kwon DY
J Parkinsons Dis; 2016 Oct; 6(4):771-778. PubMed ID: 27567887
[TBL] [Abstract][Full Text] [Related]
2. Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients.
Boccalini C; Nicastro N; Perani D; Garibotto V
Neuroimage Clin; 2024; 42():103592. PubMed ID: 38493585
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of finger and forearm movements in patients with off state early stage Parkinson's disease and scans without evidence of dopaminergic deficit (SWEDD).
Kwon DY; Kwon Y; Kim JW
Parkinsonism Relat Disord; 2018 Dec; 57():33-38. PubMed ID: 30072245
[TBL] [Abstract][Full Text] [Related]
4. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
[TBL] [Abstract][Full Text] [Related]
5. Scan without evidence of dopaminergic deficit: A 10-year retrospective study.
Nicastro N; Garibotto V; Badoud S; Burkhard PR
Parkinsonism Relat Disord; 2016 Oct; 31():53-58. PubMed ID: 27421952
[TBL] [Abstract][Full Text] [Related]
6. Kinematic analysis in patients with Parkinson's disease and SWEDD.
Lee MJ; Kim SL; Lyoo CH; Lee MS
J Parkinsons Dis; 2014; 4(3):421-30. PubMed ID: 24625831
[TBL] [Abstract][Full Text] [Related]
7. Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit.
Yu Z; Li Y;
Medicine (Baltimore); 2021 Feb; 100(7):e24837. PubMed ID: 33607852
[TBL] [Abstract][Full Text] [Related]
8. Cognition in Patients With a Clinical Diagnosis of Parkinson Disease and Scans Without Evidence of Dopaminergic Deficit (SWEDD): 2-Year Follow-Up.
Wyman-Chick KA; Martin PK; Minár M; Schroeder RW
Cogn Behav Neurol; 2016 Dec; 29(4):190-196. PubMed ID: 27984256
[TBL] [Abstract][Full Text] [Related]
9. [Questionnaire survey of Scans Without Evidence of Dopaminergic Deficit (SWEDD) in Japan].
Mukai Y; Takahashi Y; Murata M
Rinsho Shinkeigaku; 2018 Sep; 58(9):549-555. PubMed ID: 30175806
[TBL] [Abstract][Full Text] [Related]
10. A clinical approach towards smell loss in Parkinson's disease.
Haehner A; Hummel T; Reichmann H
J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
[TBL] [Abstract][Full Text] [Related]
11. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease.
Kim JE; Oh E; Park J; Youn J; Kim JS; Jang W
J Clin Neurosci; 2018 Nov; 57():131-135. PubMed ID: 30135017
[TBL] [Abstract][Full Text] [Related]
13. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
[TBL] [Abstract][Full Text] [Related]
14. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
Berendse HW; Roos DS; Raijmakers P; Doty RL
J Neurol Sci; 2011 Nov; 310(1-2):21-4. PubMed ID: 21705022
[TBL] [Abstract][Full Text] [Related]
15. Trigeminal system in Parkinson's disease: A potential avenue to detect Parkinson-specific olfactory dysfunction.
Tremblay C; Durand Martel P; Frasnelli J
Parkinsonism Relat Disord; 2017 Nov; 44():85-90. PubMed ID: 28919173
[TBL] [Abstract][Full Text] [Related]
16. Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.
Rossi M; Perez-Lloret S; Millar Vernetti P; Drucaroff L; Costanzo E; Ballesteros D; Bril A; Cerquetti D; Guinjoan S; Merello M
Mov Disord; 2015 Aug; 30(9):1275-9. PubMed ID: 26096632
[TBL] [Abstract][Full Text] [Related]
17. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
Park JW; Kwon DY; Choi JH; Park MH; Yoon HK
Parkinsonism Relat Disord; 2018 Jan; 46():69-73. PubMed ID: 29233469
[TBL] [Abstract][Full Text] [Related]
18. Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).
Suwijn SR; Samim H; Eggers C; Espay AJ; Fox S; Lang AE; Samuel M; Silverdale M; Verschuur CVM; Dijk JM; Verberne HJ; Booij J; de Bie RMA
J Parkinsons Dis; 2020; 10(4):1561-1569. PubMed ID: 32597819
[TBL] [Abstract][Full Text] [Related]
19. Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.
Taylor S; Gafton J; Shah B; Pagano G; Chaudhuri KR; Brooks DJ; Pavese N
Mov Disord; 2016 Mar; 31(3):344-51. PubMed ID: 26863920
[TBL] [Abstract][Full Text] [Related]
20. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.
Fullard ME; Morley JF; Duda JE
Neurosci Bull; 2017 Oct; 33(5):515-525. PubMed ID: 28831680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
